
| 3 min read
As therapies grow more complex, inactive ingredient innovation is needed to improve drug impact and access.
| 2 min read
New study uses simulations and machine learning to identify a single, high-impact interaction within a viral fusion protein, highlighting a potential new target for antiviral drug development.
| 9 min read
Rather than replacing radiologists, AI is working alongside them to catch cancers earlier and improve screening efficiency.
| 4 min read
Billion-dollar partnerships, Phase 1 wins, AI regulatory tools, and more led the news this week.News
Cancer Research News
QDX and Prelude Therapeutics are developing drugs that selectively target the JAK2 V617F mutation, offering hope for patients with myeloproliferative neoplasms.
Scientists created a novel platform that uses the advantages of both bacteria and viruses to attack tumors.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
A streamlined analytical strategy supports reliable plasmid and mRNA quality assessment at every mRNA production stage.
Explore how advanced functional human organ models improve preclinical drug testing and toxicity evaluation.



















